- Home
- PSNL vs DFP Comparison
PSNL vs DFP Comparison
Compare PSNL & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- DFP
- Stock Information
- Founded
- PSNL 2011
- DFP 2013
- Country
- PSNL United States
- DFP United States
- Employees
- PSNL N/A
- DFP N/A
- Industry
- PSNL Medical Specialities
- DFP Investment Managers
- Sector
- PSNL Health Care
- DFP Finance
- Exchange
- PSNL Nasdaq
- DFP Nasdaq
- Market Cap
- PSNL 460.7M
- DFP 418.8M
- IPO Year
- PSNL 2019
- DFP N/A
- Fundamental
- Price
- PSNL $4.72
- DFP $20.48
- Analyst Decision
- PSNL Strong Buy
- DFP
- Analyst Count
- PSNL 4
- DFP 0
- Target Price
- PSNL $7.81
- DFP N/A
- AVG Volume (30 Days)
- PSNL 1.1M
- DFP 56.2K
- Earning Date
- PSNL 02-27-2025
- DFP 01-01-0001
- Dividend Yield
- PSNL N/A
- DFP 6.73%
- EPS Growth
- PSNL N/A
- DFP N/A
- EPS
- PSNL N/A
- DFP N/A
- Revenue
- PSNL $87,489,000.00
- DFP N/A
- Revenue This Year
- PSNL $16.00
- DFP N/A
- Revenue Next Year
- PSNL $1.29
- DFP N/A
- P/E Ratio
- PSNL N/A
- DFP N/A
- Revenue Growth
- PSNL 24.05
- DFP N/A
- 52 Week Low
- PSNL $1.14
- DFP $15.45
- 52 Week High
- PSNL $7.20
- DFP $19.31
- Technical
- Relative Strength Index (RSI)
- PSNL 43.46
- DFP 49.69
- Support Level
- PSNL $4.47
- DFP $20.57
- Resistance Level
- PSNL $6.43
- DFP $20.80
- Average True Range (ATR)
- PSNL 0.51
- DFP 0.19
- MACD
- PSNL 0.00
- DFP 0.00
- Stochastic Oscillator
- PSNL 12.50
- DFP 43.97
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.
Flaherty & Crumrine Pref&Inc Allocation is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.